Phase II trial of RAD001 [everlolimus] in relapsed/refractory multiple myeloma.
Phase of Trial: Phase II
Latest Information Update: 13 May 2011
At a glance
- Drugs Everolimus (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jul 2010 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.